Search
for
Sort by
Research 61–90 of 1000+
- Caution in the time of rashes and COVID-19
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- Plasma Therapy Gains Attention in Treatment of Viral Infections, Dermatological Illness, and Orthopedic Illnesses
- Advances in nucleoside monophosphate prodrugs as anti-HCV agents
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Teledermatology in the COVID-19 pandemic: A systematic review
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- COVID-19: The experience from Iran
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Severe Acute Respiratory Syndrome (SARS)
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management
- Prenatal serological diagnosis of intrauterine cytomegalovirus infection.
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Assessment of Cytokine-Mediated Signaling Pathway Dysregulation in Arm Skin After CO2 Laser Therapy
- Systemic Autoimmune Diseases
- COVID-19 pandemic: what about the gonads?
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- It’s X-Related: Biological Bases of Increased COVID-19 Morbidity and Mortality in Men